Statins Have an Anti-Inflammation in CKD Patients: A Meta-Analysis of Randomized Trials
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Statins Have an Anti-Inflammation in CKD Patients: A Meta-Analysis of Randomized Trials
Authors
Keywords
-
Journal
Biomed Research International
Volume 2022, Issue -, Pages 1-12
Publisher
Hindawi Limited
Online
2022-10-23
DOI
10.1155/2022/4842699
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Statin Therapy for Hyperlipidemic Patients With Chronic Kidney Disease and End-Stage Renal Disease: A Retrospective Cohort Study Based on 925,418 Adults in Taiwan
- (2022) Fung-Chang Sung et al. Frontiers in Pharmacology
- Statin ameliorates adipose inflammation via NLRP3 suppression
- (2020) Min Tong et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Inflammation and Oxidative Stress in Chronic Kidney Disease—Potential Therapeutic Role of Minerals, Vitamins and Plant-Derived Metabolites
- (2020) Shara Francesca Rapa et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Statins reduce vascular inflammation in atherogenesis: A review of underlying molecular mechanisms
- (2020) Luca Liberale et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Reactive Oxygen Species and Redox Signaling in Chronic Kidney Disease
- (2020) Maria V. Irazabal et al. Cells
- Macrophage M1/M2 polarization
- (2020) Chen Yunna et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Trends in Statin Use Among US Adults With Chronic Kidney Disease, 1999–2014
- (2019) Matthew T. Mefford et al. Journal of the American Heart Association
- Statin therapy and erythropoiesis-stimulating agent hyporesponsiveness in patients with nondialysis chronic kidney disease
- (2019) Zhun Sui et al. MEDICINE
- Statins and Inflammation: New Therapeutic Opportunities in Psychiatry
- (2019) Sung-Wan Kim et al. Frontiers in Psychiatry
- Effect of different types of statins on kidney function decline and proteinuria: a network meta-analysis
- (2019) K. Esmeijer et al. Scientific Reports
- Inflammation-Related Mechanisms in Chronic Kidney Disease Prediction, Progression, and Outcome
- (2018) Simona Mihai et al. Journal of Immunology Research
- Comparison of statin plus ezetimibe with double-dose statin on lipid profiles and inflammation markers
- (2018) Na-Qiong Wu et al. Lipids in Health and Disease
- Effect of atorvastatin on iron metabolism regulation in patients with chronic kidney disease – a randomized double blind crossover study
- (2018) Anna Masajtis-Zagajewska et al. RENAL FAILURE
- The effects of statin use on inflammatory markers among patients with metabolic syndrome and related disorders: A systematic review and meta-analysis of randomized controlled trials
- (2018) Reza Tabrizi et al. PHARMACOLOGICAL RESEARCH
- The effect of statins on microalbuminuria, proteinuria, progression of kidney function, and all-cause mortality in patients with non-end stage chronic kidney disease: A meta-analysis
- (2016) Zhenhong Zhang et al. PHARMACOLOGICAL RESEARCH
- Dyslipidemia in patients with chronic kidney disease
- (2016) Matthew R. Hager et al. REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
- Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range
- (2016) Dehui Luo et al. STATISTICAL METHODS IN MEDICAL RESEARCH
- Update on Inflammation in Chronic Kidney Disease
- (2015) Oleh M. Akchurin et al. BLOOD PURIFICATION
- NF-κB in inflammation and renal diseases
- (2015) Haisong Zhang et al. Cell and Bioscience
- Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range
- (2015) Xiang Wan et al. BMC Medical Research Methodology
- Evidence for Anti-Inflammatory Effects of Exercise in CKD
- (2014) J. L. Viana et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Simvastatin attenuates angiotensin II-induced inflammation and oxidative stress in human mesangial cells
- (2014) FENGXIANG ZHANG et al. Molecular Medicine Reports
- Anti-Inflammatory Interventions in End-stage Kidney Disease: A Randomized, Double-Blinded, Controlled and Crossover Clinical Trial on the Use of Pravastatin in Continuous Ambulatory Peritoneal Dialysis
- (2013) Alfonso M. Cueto-Manzano et al. ARCHIVES OF MEDICAL RESEARCH
- Effects of atorvastatin on biomarkers of inflammation in chronic kidney disease
- (2013) Robert G. Fassett et al. CLINICAL NEPHROLOGY
- Effect of statin therapy on cardiovascular and renal outcomes in patients with chronic kidney disease: a systematic review and meta-analysis
- (2013) Wanyin Hou et al. EUROPEAN HEART JOURNAL
- Lipid-lowering treatment and inflammatory mediators in diabetes and chronic kidney disease
- (2013) Tora Almquist et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Oxidative stress in patients with cardiovascular disease and chronic renal failure
- (2013) A. Popolo et al. FREE RADICAL RESEARCH
- Statins Decrease Lung Inflammation in Mice by Upregulating Tetraspanin CD9 in Macrophages
- (2013) Yingji Jin et al. PLoS One
- Evaluation of cardiovascular disease burden and therapeutic goal attainment in US adults with chronic kidney disease: an analysis of national health and nutritional examination survey data, 2001–2010
- (2013) Andreas Kuznik et al. BMC Nephrology
- The Effect of HMG-CoA Reductase Inhibitor on Insulin Resistance in Patients Undergoing Peritoneal Dialysis
- (2012) Fa Mee Doh et al. CARDIOVASCULAR DRUGS AND THERAPY
- Association between Albuminuria, Kidney Function, and Inflammatory Biomarker Profile in CKD in CRIC
- (2012) J. Gupta et al. Clinical Journal of the American Society of Nephrology
- Prevalence of chronic kidney disease in China: a cross-sectional survey
- (2012) Luxia Zhang et al. LANCET
- Impact of intensive statin use on the level of inflammation and platelet activation in stable angina after percutaneous coronary intervention: A clinical study
- (2012) Qing Li et al. MEDICINA CLINICA
- C-Reactive Protein and Prediction of 1-Year Mortality in Prevalent Hemodialysis Patients
- (2011) J. Bazeley et al. Clinical Journal of the American Society of Nephrology
- Rosuvastatin in Diabetic Hemodialysis Patients
- (2011) H. Holdaas et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Statins, inflammation and kidney disease
- (2011) Vera Krane et al. Nature Reviews Nephrology
- Statins and inflammation: an update
- (2010) Petter Quist-Paulsen CURRENT OPINION IN CARDIOLOGY
- Efficacy of Rosuvastatin Among Men and Women With Moderate Chronic Kidney Disease and Elevated High-Sensitivity C-Reactive Protein
- (2010) Paul M. Ridker et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- NF- B in Renal Inflammation
- (2010) A. B. Sanz et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- HDL metabolism and activity in chronic kidney disease
- (2010) Nosratola D. Vaziri et al. Nature Reviews Nephrology
- Statins--beyond lipids in CKD
- (2010) K. Amann et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Statins and Cardiovascular Diseases: From Cholesterol Lowering to Pleiotropy
- (2009) Qian Zhou et al. CURRENT PHARMACEUTICAL DESIGN
- A hydroxymethylglutaryl coenzyme a reductase inhibitor improves endothelial function within 7 days in patients with chronic hemodialysis
- (2009) Noriaki Kishimoto et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Rosuvastatin and Cardiovascular Events in Patients Undergoing Hemodialysis
- (2009) Bengt C. Fellström et al. NEW ENGLAND JOURNAL OF MEDICINE
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2009) David Moher et al. PLOS MEDICINE
- Effect of fluvastatin on serum prohepcidin levels in patients with end-stage renal disease
- (2008) Mahmut Arabul et al. CLINICAL BIOCHEMISTRY
- Effects of Lipid-Lowering Therapy with Rosuvastatin on Atherosclerotic Burden in Patients with Chronic Kidney Disease
- (2008) Yukako Sawara et al. INTERNAL MEDICINE
- Effects of Atorvastatin on Lp(a) and Lipoprotein Profiles in Hemodialysis Patients
- (2007) Melanie S Joy et al. ANNALS OF PHARMACOTHERAPY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started